Trump’s Tylenol Alert: FDA Advisory on Pregnancy & Autism Explained

On September 22, 2025, the White House and federal health officials announced a new FDA advisory urging greater caution with acetaminophen (Tylenol) use during pregnancy amid studies that show possible associations with neurodevelopmental outcomes. This video breaks down exactly what the FDA notice and White House statements say, the peer-reviewed evidence behind the claims, how doctors are reacting, and what pregnant people should actually do next. Key takeaways: * The FDA has signaled caution and is pursuing label and communication updates — but causation has not been established. * Large, well-controlled studies reduce the likelihood of a direct causal effect; experts emphasize careful, clinical decision-making rather than panic. * Pregnant people should consult their healthcare provider before changing medication regimens. Sources: FDA notice to clinicians, Reuters, The Guardian, JAMA / large Swedish cohort studies; statements from ACOG and other medical societies. (Pinned comment will include direct links to each source.) Subscribe for clear, evidence-based health updates. Comment below: What question should we ask experts in our follow-up interview?